(CME) CME - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US12572Q1058

CME: Futures, Options, Clearing, Data

CME Group Inc. (NASDAQ:CME) is a global leader in derivatives markets, providing a comprehensive platform for trading futures and options across major asset classes. The company operates exchanges for interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals. It also offers fixed income and foreign currency trading services, catering to a diverse client base that includes professional traders, financial institutions, investors, corporations, and governments. Beyond trading, CME Group provides critical infrastructure for derivatives markets, including clearing, settling, and guaranteeing contracts, as well as trade processing and risk mitigation services. Its market data services deliver real-time and historical data, enabling market participants to make informed decisions. The company, originally founded in 1898 as the Chicago Mercantile Exchange, has evolved into one of the worlds most trusted financial market operators, with a strong reputation for innovation and operational reliability.

CME Groups business model is supported by its dominance in benchmark contracts, such as the S&P 500 futures and the Eurodollar futures, which are widely regarded as global standards for risk management. The company has also expanded into emerging areas, such as cryptocurrency derivatives, to align with evolving market demands. Its revenue streams are diversified across transaction fees, clearing services, and market data, providing resilience against market volatility. CME Groups strategic focus on advancing sustainability initiatives and fostering digital transformation further underscores its commitment to long-term growth and industry leadership.

Based on the provided and , here is a 3-month forecast for CME Group Inc. (NASDAQ:CME): - Technical Outlook: - The stock is currently trading above its SMA 20 (261.00) and SMA 50 (255.82), indicating short-term bullish momentum. - The SMA 200 (224.72) remains well below current prices, suggesting a longer-term uptrend. - With an ATR of 5.80, price fluctuations are expected to remain moderate, supporting a stable ascent. - The last price of 262.53 is near the upper end of recent ranges, signaling potential for further upside. - Fundamental Outlook: - A market cap of $95029.40M USD reflects the companys strong financial position and market dominance. - The forward P/E of 24.57 suggests investor confidence in future earnings growth. - The P/S ratio of 15.53 indicates a premium valuation, consistent with the companys leadership in its industry. - An RoE of 13.19% highlights efficient profitability and robust capital utilization. - 3-Month Price Target: - Technical indicators and fundamental strength suggest a target range of $270-$285 over the next three months, supported by continued demand for derivatives trading and CME Groups strategic initiatives.

Additional Sources for CME Stock

CME Stock Overview

Market Cap in USD 101,063m
Sector Financial Services
Industry Financial Data & Stock Exchanges
GiC Sub-Industry Financial Exchanges & Data
IPO / Inception 2002-12-06

CME Stock Ratings

Growth Rating 69.9
Fundamental 74.7
Dividend Rating 76.3
Rel. Strength 13.8
Analysts 3.39/5
Fair Price Momentum 312.49 USD
Fair Price DCF 227.77 USD

CME Dividends

Dividend Yield 12m 4.19%
Yield on Cost 5y 6.99%
Annual Growth 5y 12.00%
Payout Consistency 95.5%

CME Growth Ratios

Growth Correlation 3m 82.6%
Growth Correlation 12m 95.9%
Growth Correlation 5y 74.6%
CAGR 5y 13.41%
CAGR/Max DD 5y 0.42
Sharpe Ratio 12m 2.04
Alpha 34.32
Beta 0.117
Volatility 19.68%
Current Volume 1620.1k
Average Volume 20d 2085.2k
What is the price of CME stocks?
As of May 09, 2025, the stock is trading at USD 281.99 with a total of 1,620,116 shares traded.
Over the past week, the price has changed by +1.76%, over one month by +10.57%, over three months by +17.19% and over the past year by +39.28%.
Is CME a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, CME (NASDAQ:CME) is currently (May 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 74.66 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CME as of May 2025 is 312.49. This means that CME is currently undervalued and has a potential upside of +10.82% (Margin of Safety).
Is CME a buy, sell or hold?
CME has received a consensus analysts rating of 3.39. Therefor, it is recommend to hold CME.
  • Strong Buy: 4
  • Buy: 3
  • Hold: 7
  • Sell: 4
  • Strong Sell: 0
What are the forecast for CME stock price target?
According to ValueRays Forecast Model, CME CME will be worth about 337.5 in May 2026. The stock is currently trading at 281.99. This means that the stock has a potential upside of +19.68%.
Issuer Forecast Upside
Wallstreet Target Price 270.4 -4.1%
Analysts Target Price 270.4 -4.1%
ValueRay Target Price 337.5 19.7%